Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment.
作者信息
Ding Yutong, Zhang Yuting, Su Xiaofen, Wu Yanjuan, Zhang Nuofu, Wu Kang
机构信息
Sleep Medicine Center, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, National Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
出版信息
Am J Respir Crit Care Med. 2025 Aug;211(8):1531-1532. doi: 10.1164/rccm.202504-0842LE.
Abstract
摘要
相似文献
1
Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment.伊马替尼：肺动脉高压治疗中一颗充满希望的治疗新星。
Am J Respir Crit Care Med. 2025 Aug;211(8):1531-1532. doi: 10.1164/rccm.202504-0842LE.
2
Reply to Ding : Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment.回复丁：伊马替尼：肺动脉高压治疗中一颗充满希望的治疗新星。
Am J Respir Crit Care Med. 2025 Aug;211(8):1533-1534. doi: 10.1164/rccm.202504-0926LE.
3
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study.伊马替尼用于肺动脉高压的定位：一项剂量探索性2期研究。
Am J Respir Crit Care Med. 2025 Jun;211(6):1018-1027. doi: 10.1164/rccm.202410-1929OC.
4
Efficacy and Safety of Treating Pulmonary Arterial Hypertension With Imatinib: A Meta-Analysis of Randomized Controlled Trials.伊马替尼治疗肺动脉高压的疗效与安全性：一项随机对照试验的荟萃分析
J Cardiovasc Pharmacol. 2025 Mar 1;85(3):177-185. doi: 10.1097/FJC.0000000000001665.
5
Drugs targeting novel pathways in pulmonary arterial hypertension.靶向肺动脉高压新通路的药物。
Eur Respir J. 2025 Aug 8;66(2). doi: 10.1183/13993003.01830-2024. Print 2025 Aug.
6
Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats.酪氨酸激酶抑制剂是大鼠体内强效的急性肺血管扩张剂。
Am J Respir Cell Mol Biol. 2011 Oct;45(4):804-8. doi: 10.1165/rcmb.2010-0371OC. Epub 2011 Mar 4.
7
Pulmonary Arterial Hypertension Onset in an Adult Woman With a TBX4 Likely Pathogenic Variant Following Imatinib Administration: A Case Report.伊马替尼治疗后一名携带可能致病的TBX4变异的成年女性发生肺动脉高压：病例报告
Am J Med Genet A. 2025 Jul 4:e64178. doi: 10.1002/ajmg.a.64178.
8
Colchicine as a therapeutic possibility for the treatment of pulmonary arterial hypertension (PAH) in a rat model.秋水仙碱作为大鼠模型中治疗肺动脉高压（PAH）的一种治疗可能性。
Biochem Pharmacol. 2025 Sep;239:117058. doi: 10.1016/j.bcp.2025.117058. Epub 2025 Jun 24.
9
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.长期应用伊马替尼治疗肺动脉高压的安全性和疗效。
J Heart Lung Transplant. 2015 Nov;34(11):1366-75. doi: 10.1016/j.healun.2015.05.025. Epub 2015 Jun 11.
10
Melatonin: shining some light on pulmonary hypertension.褪黑素：为肺动脉高压带来曙光。
Cardiovasc Res. 2020 Nov 1;116(13):2036-2037. doi: 10.1093/cvr/cvaa173.
本文引用的文献
1
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study.伊马替尼用于肺动脉高压的定位：一项剂量探索性2期研究。
Am J Respir Crit Care Med. 2025 Jun;211(6):1018-1027. doi: 10.1164/rccm.202410-1929OC.
2
Pulmonary Hypertension: A Contemporary Review.肺动脉高压：当代综述。
Am J Respir Crit Care Med. 2023 Sep 1;208(5):528-548. doi: 10.1164/rccm.202302-0327SO.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
4
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.长期应用伊马替尼治疗肺动脉高压的安全性和疗效。
J Heart Lung Transplant. 2015 Nov;34(11):1366-75. doi: 10.1016/j.healun.2015.05.025. Epub 2015 Jun 11.
5
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.甲磺酸伊马替尼作为肺动脉高压的附加治疗：随机 IMPRES 研究的结果。
Circulation. 2013 Mar 12;127(10):1128-38. doi: 10.1161/CIRCULATIONAHA.112.000765. Epub 2013 Feb 12.
6
Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response.CYP3A4 的自动抑制导致 CYP2C8 在伊马替尼代谢中发挥重要作用：CYP2C8 活性的变异性可能改变血浆浓度和反应。
Drug Metab Dispos. 2013 Jan;41(1):50-9. doi: 10.1124/dmd.112.048017. Epub 2012 Oct 1.
7
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.血小板衍生生长因子在特发性肺动脉高压中的表达与功能
Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8. doi: 10.1164/rccm.200707-1037OC. Epub 2008 Apr 17.
8
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension.甲磺酸伊马替尼治疗难治性特发性肺动脉高压
Ann Intern Med. 2006 Jul 18;145(2):152-3. doi: 10.7326/0003-4819-145-2-200607180-00020.
9
Reversal of experimental pulmonary hypertension by PDGF inhibition.通过抑制血小板衍生生长因子（PDGF）逆转实验性肺动脉高压
J Clin Invest. 2005 Oct;115(10):2811-21. doi: 10.1172/JCI24838.
10
Imatinib for the treatment of pulmonary arterial hypertension.伊马替尼用于治疗肺动脉高压。
N Engl J Med. 2005 Sep 29;353(13):1412-3. doi: 10.1056/NEJMc051946.
Zotero 插件